| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.004 | 0.826 | Anticonvulsant | 0.197 0.085 CID_154699860 | ||
| 0.718 | 0.001 | 0.718 | Benzodiazepine receptor peripheral-type antagonist | 0.233 0.002 CID_154699860 | ||
| 0.592 | 0.001 | 0.592 | Benzodiazepine antagonist | 0.054 0.019 CID_154699860 | ||
| 0.492 | 0.003 | 0.492 | GABA A receptor antagonist | 0.166 0.007 CID_154699860 | ||
| 0.468 | 0.003 | 0.468 | GABA receptor antagonist | 0.172 0.008 CID_154699860 | ||
| 0.458 | 0.062 | 0.458 | Analgesic | |||
| 0.408 | 0.017 | 0.408 | Transcription factor STAT inhibitor | 0.262 0.079 CID_154699860 | ||
| 0.354 | 0.003 | 0.354 | Benzodiazepine agonist | 0.114 0.018 CID_154699860 | ||
| 0.347 | 0.005 | 0.347 | GABA receptor agonist | 0.278 0.008 CID_154699860 | ||
| 0.315 | 0.004 | 0.315 | GABA A receptor agonist | 0.238 0.007 CID_154699860 | ||
| 0.329 | 0.041 | 0.329 | Transcription factor STAT3 inhibitor | 0.243 0.089 CID_154699860 | ||
| 0.362 | 0.138 | 0.362 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.312 | 0.152 | 0.312 | 5 Hydroxytryptamine release inhibitor | |||
| 0.166 | 0.018 | 0.166 | Hedgehog signaling inhibitor | |||
| 0.182 | 0.037 | 0.182 | Neurotrophic factor | 0.165 0.047 CID_154699860 | ||
| 0.165 | 0.041 | 0.165 | Glutamate receptor antagonist | |||
| 0.139 | 0.033 | 0.139 | Transcription factor STAT6 inhibitor | |||
| 0.279 | 0.175 | 0.438 | Calcium channel L-type activator | 0.438 0.057 CID_154699860 | CID_154699860 | |
| 0.201 | 0.114 | 0.209 | DNA damaging | 0.209 0.108 CID_154699860 | CID_154699860 | |
| 0.105 | 0.027 | 0.113 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.113 0.024 CID_154699860 | CID_154699860 | |
| 0.119 | 0.057 | 0.119 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.082 | 0.025 | 0.082 | Orexin receptor antagonist | |||
| 0.089 | 0.037 | 0.089 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.155 | 0.109 | 0.155 | Anesthetic general | |||
| 0.082 | 0.036 | 0.082 | Glutamate (mGluR group I) antagonist | |||
| 0.05 | 0.007 | 0.05 | Kainate receptor 4 antagonist | 0.028 0.015 CID_154699860 | ||
| 0.086 | 0.044 | 0.086 | Glutamate (mGluR) antagonist | |||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | |||
| 0.052 | 0.014 | 0.052 | Vascular adhesion protein 1 inhibitor | |||
| 0.077 | 0.04 | 0.077 | Orexin receptor 1 antagonist | |||
| 0.096 | 0.06 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.058 | 0.023 | 0.058 | Glutamate (mGluR5) antagonist | |||
| 0.053 | 0.018 | 0.053 | Guanylate cyclase stimulant | |||
| 0.1 | 0.066 | 0.1 | Gastric antisecretory | |||
| 0.059 | 0.027 | 0.147 | H+/K+-transporting ATPase inhibitor | 0.147 0.005 CID_154699860 | CID_154699860 | |
| 0.084 | 0.052 | 0.084 | Caspase 7 inhibitor | |||
| 0.06 | 0.031 | 0.06 | NMDA 2B receptor antagonist | |||
| 0.13 | 0.103 | 0.13 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.213 | 0.191 | 0.213 | GABA C receptor rho-3 antagonist | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.029 | 0.007 | 0.029 | Guanylate cyclase 1 stimulant | |||
| 0.101 | 0.083 | 0.101 | Activin receptor-like kinase 4 inhibitor | |||
| 0.118 | 0.1 | 0.118 | Nav1.6 sodium channel blocker | |||
| 0.028 | 0.01 | 0.028 | Kainate receptor 5 antagonist | |||
| 0.066 | 0.05 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.022 | 0.008 | 0.022 | Kainate receptor 3 antagonist | |||
| 0.037 | 0.024 | 0.037 | Orexin receptor 2 antagonist | |||
| 0.066 | 0.055 | 0.066 | Transforming growth factor antagonist | |||
| 0.041 | 0.032 | 0.041 | Angiotensin AT1 receptor antagonist | |||
| 0.033 | 0.025 | 0.033 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.164 | 0.156 | 0.164 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.128 | 0.124 | 0.137 | CF transmembrane conductance regulator agonist | 0.137 0.101 CID_154699860 | CID_154699860 | |
| 0.026 | 0.024 | 0.026 | Glucosylceramidase stimulant | |||
| 0.092 | 0.091 | 0.092 | Anesthetic local | |||
| 0.038 | 0.117 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 CID_154699860 | CID_154699860 | |
| 0.151 | 0.357 | 0.261 | Apoptosis agonist | 0.261 0.203 CID_154699860 | CID_154699860 | |
| 0.07 | 0.41 | 0.233 | Lipocortins synthesis antagonist | 0.233 0.039 CID_154699860 | CID_154699860 | |
| 0.035 | 0.398 | 0.079 | Thioredoxin reductase inhibitor | 0.079 0.064 CID_154699860 | CID_154699860 | |
| 0.103 | 0.522 | 0.308 | Antiinflammatory | 0.308 0.208 CID_154699860 | CID_154699860 | |
| 0.064 | 0.71 | 0.24 | Interleukin 2 agonist | 0.24 0.13 CID_154699860 | CID_154699860 | |
| 0.02 | 0.689 | 0.086 | Interleukin 5 antagonist | 0.086 0.061 CID_154699860 | CID_154699860 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |